Rodgers Richard J
SEC CIK 1313397 · EDGAR
Most active insiders at NVAX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Draghia-Akli Ruxandra | Section 16 | — | — |
| 2 | O'Hara Elaine | EVP, Chief Strategy Off | — | — |
| 3 | Shiver John W. | Dir | — | — |
| 4 | Newton Charles W. | Dir | — | — |
| 5 | Jacobs John C | Pres, CEO, Dir | — | — |
| 6 | King Rachel K. | Dir | — | — |
| 7 | Kelly James Patrick | EVP, CFO, Treas | — | — |
| 8 | Casey Mark J | EVP, CLO | — | — |
| 9 | Alton Gregg H | Dir | — | — |
| 10 | Rodgers Richard J | Dir | — | — |
Transactions 25
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-06-23 19:58 | 2026-06-20 | NVAX | NOVAVAX INC | Rodgers Richard J | Dir | M - OptEx | — | +18.9K | 47.4K | +66% | — |
| D | 2026-06-18 16:08 | 2026-06-16 | ARDX | ARDELYX, INC. | Rodgers Richard J | Dir | A - Grant | $0.00 | +26.5K | 440.0K | +6% | $0 |
| 2026-04-22 16:32 | 2026-04-20 | IRD | Opus Genetics, Inc. | Rodgers Richard J | Dir | A - Grant | $0.00 | +24.4K | 343.0K | +8% | $0 | |
| D | 2025-10-30 | 2025-10-29 | NVAX | NOVAVAX INC | Rodgers Richard J | Dir | M - OptEx | — | +3,800 | 28.5K | +15% | — |
| DM | 2025-06-23 | 2025-06-18 | ARDX | ARDELYX, INC. | Rodgers Richard J | Dir | A - Grant | $0.00 | +63.0K | 372.0K | +20% | $0 |
| D | 2025-06-13 | 2025-06-12 | NVAX | NOVAVAX INC | Rodgers Richard J | Dir | M - OptEx | $0.00 | +10.4K | 24.7K | +73% | $0 |
| D | 2025-05-02 | 2025-04-30 | IRD | Opus Genetics, Inc. | Rodgers Richard J | Dir | A - Grant | $0.00 | +79.5K | 318.7K | +33% | $0 |
| D | 2025-01-17 | 2025-01-16 | ARDX | ARDELYX, INC. | Rodgers Richard J | Dir | M - OptEx | $0.55 | +100.0K | 350.5K | +40% | +$55.0K |
| D | 2025-01-02 | 2024-10-29 | NVAX | NOVAVAX INC | Rodgers Richard J | Dir | M - OptEx | $0.00 | +3,800 | 14.3K | +36% | $0 |
| D | 2024-06-17 | 2024-06-14 | ARDX | ARDELYX, INC. | Rodgers Richard J | Dir | A - Grant | $0.00 | +12.2K | 250.5K | +5% | $0 |
| D | 2024-06-14 | 2024-06-12 | NVAX | NOVAVAX INC | Rodgers Richard J | Dir | M - OptEx | $0.00 | +6,670 | 10.5K | +176% | $0 |
| D | 2024-06-13 | 2024-06-11 | IRD | Opus Genetics, Inc. | Rodgers Richard J | Dir | A - Grant | $0.00 | +41.1K | 239.2K | +21% | $0 |
| 2024-01-03 | 2024-01-01 | IRD | Opus Genetics, Inc. | Rodgers Richard J | Dir | A - Grant | — | +24.8K | 198.0K | +14% | — | |
| 2023-11-13 | 2023-11-01 | IRD | Opus Genetics, Inc. | Rodgers Richard J | Dir | A - Grant | $0.00 | +35.0K | 173.2K | +25% | $0 | |
| D | 2023-10-31 | 2023-10-29 | NVAX | NOVAVAX INC | Rodgers Richard J | Dir | M - OptEx | — | +3,800 | 3,800 | New | — |
| D | 2023-06-16 | 2023-06-15 | ARDX | ARDELYX, INC. | Rodgers Richard J | Dir | A - Grant | $0.00 | +18.5K | 238.3K | +8% | $0 |
| 2023-04-21 | 2023-04-19 | IRD | Opus Genetics, Inc. | Rodgers Richard J | Pres, Interim CEO, Dir | A - Grant | $0.00 | +50.0K | 138.2K | +57% | $0 | |
| 2023-01-12 | 2023-01-11 | IRD | Opus Genetics, Inc. | Rodgers Richard J | Dir | A - Grant | — | +20.8K | 88.2K | +31% | — | |
| D | 2022-10-04 | 2022-10-03 | IRD | Opus Genetics, Inc. | Rodgers Richard J | Dir | X - OptEx | $0.00 | +3,148 | 67.4K | +5% | $0 |
| M | 2022-07-06 | 2022-07-01 | IRD | Opus Genetics, Inc. | Rodgers Richard J | Dir | A - Grant | — | +23.7K | 64.3K | +58% | — |
| D | 2022-06-17 | 2022-06-15 | ARDX | ARDELYX, INC. | Rodgers Richard J | Dir | A - Grant | $0.00 | +132.3K | 219.8K | +151% | $0 |
| 2022-04-05 | 2022-04-01 | IRD | Opus Genetics, Inc. | Rodgers Richard J | Dir | A - Grant | — | +4,629 | 40.6K | +13% | — | |
| 2022-01-05 | 2022-01-03 | IRD | Opus Genetics, Inc. | Rodgers Richard J | Dir | A - Grant | — | +4,021 | 36.0K | +13% | — | |
| 2021-10-04 | 2021-10-01 | IRD | Opus Genetics, Inc. | Rodgers Richard J | Dir | A - Grant | — | +2,912 | 32.0K | +10% | — | |
| 2021-07-02 | 2021-07-01 | IRD | Opus Genetics, Inc. | Rodgers Richard J | Dir | A - Grant | — | +2,840 | 29.1K | +11% | — |
Purchase Sale Sale after option exercise All abbreviations